Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

    

For the Three Months Ended

March 31, 

    

2022

    

2021

Warrants [1]

5,122,074

5,234,721

Restricted stock units

855,989

Restricted stock awards

307,791

Stock options

 

94,447

 

117,261

 

6,380,301

 

5,351,982

[1]   The 2022 period includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.The 2021 period includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.